FDA Approval of VBLOC® Vagal Blocking Therapy for the Treatment of Obesity

EnteroMedics Announces FDA Approval of  VBLOC® Vagal Blocking Therapy for the Treatment of ObesityFirst New Medical Device Approved for Obesity in Over a Decade
Novel Neuroscience–Based Technology Enables Safe, Durable Weight Loss
Company to Host Conference Call Today at 12:00 PM ET Continue reading